Ad
ABBV Short Information AbbVie Inc.
home / stock / abbv / abbv short
Short Information | AbbVie Inc. (NYSE:ABBV)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 619,116 |
| Total Actual Volume | 117,989,516 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 30,956 |
| Average Short Percentage | 0.53% |
Is there a ABBV Short Squeeze or Breakout about to happen?
See the ABBV Short Analysis for free Sign up or Login
Powered by Squeeze Report
ABBV Twenty Trading Day's Volume to Short Volume Chart
ABBV Twenty Trading Day Price Chart
ABBV Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $170.3 | $169.2 | $170.8684 | $168.06 | 8,420,910 | 98,209 | 1.17% |
| 01-21-2025 | $172.16 | $172.61 | $175.66 | $171.22 | 7,548,666 | 18,803 | 0.25% |
| 01-17-2025 | $172.88 | $171.56 | $173.99 | $171.27 | 7,852,525 | 118,042 | 1.5% |
| 01-16-2025 | $171.45 | $173.7 | $173.9567 | $170.52 | 5,235,975 | 34,232 | 0.65% |
| 01-15-2025 | $173.515 | $171.35 | $174.46 | $168.72 | 8,048,736 | 42,774 | 0.53% |
| 01-14-2025 | $176.61 | $175.55 | $176.78 | $174.09 | 4,779,147 | 28,066 | 0.59% |
| 01-13-2025 | $175.16 | $176.74 | $177.98 | $174.34 | 4,734,094 | 18,729 | 0.4% |
| 01-10-2025 | $176.86 | $175.17 | $177.54 | $173.33 | 5,372,441 | 31,742 | 0.59% |
| 01-08-2025 | $179.2 | $178.5 | $179.24 | $176.18 | 4,488,519 | 53,534 | 1.19% |
| 01-07-2025 | $179.63 | $179.53 | $182.1725 | $178.389 | 5,905,223 | 17,536 | 0.3% |
| 01-06-2025 | $180.78 | $180.1 | $181.98 | $179.26 | 6,302,081 | 26,051 | 0.41% |
| 01-03-2025 | $179.66 | $181.22 | $181.57 | $178.8 | 4,380,336 | 10,988 | 0.25% |
| 01-02-2025 | $178.66 | $179.44 | $179.78 | $177.9006 | 4,094,307 | 21,726 | 0.53% |
| 12-31-2024 | $176.35 | $177.7 | $177.84 | $175.92 | 3,326,732 | 24,679 | 0.74% |
| 12-30-2024 | $177.02 | $176.2 | $177.34 | $175.5101 | 3,405,687 | 9,386 | 0.28% |
| 12-27-2024 | $177.92 | $178.01 | $179.66 | $177.29 | 2,745,373 | 6,639 | 0.24% |
| 12-26-2024 | $179.02 | $179.2 | $180.35 | $178.63 | 2,759,421 | 13,064 | 0.47% |
| 12-24-2024 | $178.41 | $180 | $180.17 | $177.8408 | 2,692,814 | 6,124 | 0.23% |
| 12-23-2024 | $175.29 | $178.39 | $178.65 | $174.63 | 6,945,621 | 18,034 | 0.26% |
| 12-20-2024 | $171.794 | $175.58 | $176.8 | $170.66 | 18,950,908 | 20,758 | 0.11% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology PR Newswire Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platform ...
-
2025-01-21 18:22:12 ET Many products sold by companies aren't must-have items. However, healthcare is a necessity. And the healthcare sector is poised to grow over the next decade and beyond with aging populations around the world. These factors make healthcare stocks a great addition t...
-
2025-01-21 07:10:00 ET You've probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs doctors and patients rely on -- and that means no matter what the economy is doing, doctors will continue prescr...